focalinterest.net

Tag: Neuroscience & Neural Engineering

  • iPSC neurons showed three distinct functional network patterns over time

    What the study found

    The study found that human induced pluripotent stem cell-derived neurons showed three distinct patterns of activity and network organization across a 55-day culture period. These patterns appeared to match different stages of neural maturation.

    Why the authors say this matters

    The authors conclude that these findings shed light on the microscale organisation of neural networks in vitro, meaning the small-scale organization of nerve-cell networks studied outside the body. They also say the work offers a foundational understanding of in-vitro neuronal network dynamics that may be valuable for future research on brain function and disorders.

    What the researchers tested

    The researchers recorded spontaneous neuronal activity from human induced pluripotent stem cell-derived neurons using a multi-electrode array, a device that measures electrical activity across many sites at once. They tracked spikes, bursts, and functional connectivity across 20 non-consecutive days over 55 days of culture.

    What worked and what didn't

    In the early period, the neurons showed a gradually increasing number of synchronous spikes, firing frequency, network bursts, and burst rate. In the mid period, the neurons showed a fully mature synchronisation pattern with stable spiking and bursting behaviours, while in the later period the firing rate, number of bursts, and network bursts decreased.

    What to keep in mind

    The abstract does not describe broader experimental limits beyond the culture-based setting and the specific days sampled. Staining was reported only for day 21 and day 28, so the summary does not provide details about longer-term synaptic changes beyond those time points.

    • The study identified three distinct activity patterns during 55 days of culture.
    • Early-stage neurons showed increasing synchronous spiking, bursting, and firing frequency.
    • Mid-stage neurons showed stable spiking and bursting with a mature synchronisation pattern.
    • Later-stage neurons showed decreases in firing rate, bursts, and network bursts.
    • Staining on days 21 and 28 showed significant changes in mean presynaptic and postsynaptic volumes.

  • Organic event-based sensors detect neural activity with low energy

    What the study found

    The study reports an organic electrochemical neuron-based sensor that can detect neural activity rapidly and with low energy use. The authors say it can also support closed-loop neurostimulation, meaning sensing and stimulation are linked in real time.

    Why the authors say this matters

    The authors conclude that these sensors are candidates for the next generation of implantable bioelectronics in energy-constrained environments. They suggest the combination of biorealistic operation and ultra-low energy use is important for this use case.

    What the researchers tested

    The researchers developed an organic electrochemical neuron (OECN)-based event-driven sensor, a type of sensor that converts neural activity into electrical events. They tested its response speed, voltage pulse rate, and energy use, and integrated it with microelectrodes for in vivo neurostimulation experiments.

    What worked and what didn't

    The sensors responded within about 1 millisecond and produced voltage pulses up to 1.1 kHz, covering the stated 0.5-1,000 Hz bandwidth of mammalian neuronal activity. They used about 40 pJ per spike, and the abstract says they accurately detected hippocampal interictal epileptiform discharges and suppressed pathological sleep spindle oscillations in vivo with real-time stimulation. The abstract also notes that conventional silicon interfaces are rigid and energy intensive, while earlier OECN-based sensors had been limited by slow firing rates, high energy use, and scalability challenges.

    What to keep in mind

    The abstract does not provide detailed study limitations, sample sizes, or long-term performance data. It also does not describe how broadly the results would generalize beyond the specific neural signals and in vivo conditions reported.

    • The study reports an OECN-based sensor for real-time neural detection and closed-loop neurostimulation.
    • The sensor responded within about 1 millisecond and used about 40 pJ per spike.
    • The abstract says the device produced voltage pulses up to 1.1 kHz.
    • Accurate detection of hippocampal interictal epileptiform discharges was demonstrated.
    • Integrated with microelectrodes, the system delivered real-time stimulation to suppress pathological sleep spindle oscillations in vivo.

  • NeuroGator reduces data throughput in implantable BCI systems

    What the study found

    NeuroGator, an asynchronous gating system for implantable brain-computer interfaces (BCIs), reduced data throughput while keeping performance high. The abstract reports an F1-score of 0.95, an 82% reduction in overall data throughput, and more than 85% of operation time spent in an ultra-low-power state.

    Why the authors say this matters

    The authors say the system addresses the resource efficiency bottleneck in implantable BCI devices, especially for power-constrained wireless systems. They conclude that NeuroGator offers a paradigm for next-generation asynchronous implantable BCI systems.

    What the researchers tested

    The researchers tested NeuroGator, which uses local field potential (LFP, electrical signals recorded from brain tissue) brain-state estimation in two stages. A low-power hardware silence detector first filters background noise and non-active signals, and a Dual-Resolution Gate Recurrent Unit model then uses low-precision and high-precision LFP analysis to decide when activity is present.

    What worked and what didn't

    The silence detector reduced data size by approximately 69.4%. The full system reduced overall data throughput by 82% while maintaining an F1-score of 0.95, and it was implemented in an application-specific integrated circuit using a standard 180 nm complementary metal oxide semiconductor process with a silicon area of 0.006 mm2 and power consumption of 51 nW.

    What to keep in mind

    The abstract does not describe study limitations, comparison conditions, or detailed test settings. It also does not provide information about performance on different datasets, subjects, or use cases beyond the reported implantable BCI context.

    • NeuroGator is an asynchronous gating system for implantable brain-computer interfaces.
    • A low-power silence detector reduced data size by about 69.4%.
    • The full system reduced overall data throughput by 82% and kept an F1-score of 0.95.
    • The system stayed in an ultra-low-power state for over 85% of its operation period.
    • The design was implemented in a 180 nm CMOS ASIC with 0.006 mm2 area and 51 nW power use.

  • Predictive models identified later emergent depression risk

    What the study found

    The best-performing model was elastic net regression, which predicted emergent major depressive disorder nine years later with an area under the curve of 0.724. The strongest linked predictors of higher risk included greater perceived stress, early life minimization and stress, family and spousal strain, and some comorbid mental health symptoms.

    Why the authors say this matters

    The authors conclude that explainable AI may help build clinically actionable long-term risk models for emergent major depressive disorder using easily measurable, theory-driven variables. They also suggest that, if externally validated, these models could be used in healthcare systems to support prevention strategies and tailored treatment strategies.

    What the researchers tested

    The researchers followed 931 community adults who did not meet diagnostic criteria for major depressive disorder at the first wave of data collection in 2004–2006. They used 46 baseline composite variables, including inflammation, childhood maltreatment, coping, emotion regulation, personality, social support, and related factors, to predict emergent major depressive disorder at a second wave in 2013–2014. Six machine-learning models with different predictor-set lengths and missing-data strategies were compared using five-fold nested cross-validation, and SHAP (Shapley additive explanations) analysis was used to examine predictor direction and strength.

    What worked and what didn't

    Elastic net regression achieved the best classification performance, with an AUC of 0.724 and 95% confidence intervals of 0.657–0.792. It showed moderate sensitivity, a high negative predictive value, and moderate-to-good calibration. Higher risk was associated with greater perceived stress, early life minimization and stress, family and spousal strain, fewer problem-focused coping strategies, lower self-acceptance, lower sense of control, lower self-directedness, greater behavioral disengagement, younger age, racial minority identity, and higher baseline generalized anxiety disorder, panic disorder, and substance use disorder symptom severity.

    What to keep in mind

    The abstract does not describe external validation, so the authors’ suggested healthcare use remains conditional on further testing. Emergent major depressive disorder occurred in 6.23% of the sample, and the summary does not provide detail on how the model would perform in other populations or settings.

    • Elastic net regression performed best for predicting emergent major depressive disorder nine years later.
    • The best model had an AUC of 0.724 and moderate sensitivity with a high negative predictive value.
    • Higher risk was linked to perceived stress, early life minimization and stress, and family or spousal strain.
    • Lower problem-focused coping, self-acceptance, sense of control, and self-directedness were associated with higher risk.
    • Younger age, racial minority identity, and higher baseline anxiety, panic, and substance use symptoms were also linked to higher risk.

  • Sex differences shape stress-induced alcohol-seeking

    What the study found

    The study found sex differences in how depression and anxiety symptoms relate to stress-induced alcohol-seeking. Generalized anxiety symptoms were associated with greater stress-induced alcohol-seeking in women but not in men, and depression showed a similar pattern without reaching statistical significance.

    Why the authors say this matters

    The authors conclude that identifying mechanisms behind sex-specific relationships with stress-induced alcohol-seeking can inform tailored intervention approaches. They suggest this may ultimately enhance treatment efficacy for both men and women.

    What the researchers tested

    This was a secondary analysis of a previously published trial of 84 adults aged 21 to 55 who reported moderate-to-heavy alcohol use. Participants completed two counterbalanced intravenous alcohol administration sessions, and 54 also completed optional neuroimaging; the analysis examined subjective alcohol responses and resting-state functional connectivity of the amygdala and hippocampus, brain regions involved in anxiety and depression.

    What worked and what didn't

    Across men and women, blunted state stimulation in response to alcohol, but not state anxiety, was associated with greater stress-induced alcohol-seeking. In men, anxiety symptoms were linked with heightened state stimulation effects, which appeared to buffer against stress-induced alcohol-seeking. Subjective alcohol responses did not mediate the relationship between depression symptoms and stress-induced alcohol-seeking, and resting-state network connectivity findings identified several potential sex-dependent neural mechanisms that warrant further investigation.

    What to keep in mind

    The study was a secondary analysis and was not originally designed as a direct test of competing theoretical models. Only 54 participants completed the optional neuroimaging component, and the abstract does not provide further limitations beyond noting that some findings warrant additional investigation.

    • Generalized anxiety symptoms were associated with greater stress-induced alcohol-seeking in women, but not in men.
    • Depression symptoms showed a similar pattern, but the results did not reach statistical significance.
    • Blunted state stimulation in response to alcohol was associated with greater stress-induced alcohol-seeking across men and women.
    • In men, anxiety symptoms were linked with heightened state stimulation effects that appeared to buffer against stress-induced alcohol-seeking.
    • Subjective alcohol responses did not mediate the depression–stress-induced alcohol-seeking relationship.
    • Resting-state connectivity of the amygdala and hippocampus suggested possible sex-dependent neural mechanisms.

  • Molecular imaging links late-life depression to neurodegenerative processes

    What the study found

    The study found that late-life depression is associated with symptom patterns and treatment responses that may reflect interacting neurotransmitter, inflammatory, and neurodegenerative processes. The authors also report that molecular imaging has revealed changes in neurotransmitter systems, Alzheimer's disease pathology, and a possible role for neuroinflammation.

    Why the authors say this matters

    The authors conclude that molecular imaging could help guide the development of targeted, mechanism-based treatments for late-life depression. They also suggest this may help reduce the burden of late-life depression and its associated vulnerability to neurodegenerative disease.

    What the researchers tested

    This is a research article reviewing what molecular imaging, especially positron emission tomography (PET), can show about late-life depression. PET is an imaging method that can examine biological processes in the body, including neurotransmitter activity and markers linked to disease.

    What worked and what didn't

    The abstract says molecular imaging studies have revealed alterations across neurotransmitter systems and Alzheimer's disease pathology, including beta-amyloid and Tau, as well as a potential role of neuroinflammation. It also says many older adults with depression do not respond to first-line antidepressant treatment, and some experience relapse and persistent symptoms such as anxiety, apathy, and cognitive impairment.

    What to keep in mind

    The abstract does not describe a single new experiment or provide numerical results. It also presents future directions, including next-generation PET tracers and multi-modal image analysis, but these are proposed directions rather than findings from the study itself.

    • Late-life depression is described as having greater disability, suicide risk, and mortality than mid-life depression.
    • The authors link late-life depression to potential neurodegenerative disease processes, including Alzheimer's disease and Parkinson's disease.
    • Molecular imaging, especially PET, is presented as a way to study neurotransmitter systems, beta-amyloid, Tau, and neuroinflammation in vivo.
    • The abstract says symptom variability and treatment response may arise from interacting molecular processes that affect synaptic plasticity.
    • Future work is said to include new PET tracers for glutamatergic signaling, mitochondrial function, histone deacetylase activity, and cell-type-specific inflammation.

  • Brief electrical stimulation produced ketamine-like plasticity in human dopaminergic neurons

    What the study found

    A single brief exposure to low-frequency, low-intensity electrical stimulation produced ketamine-like structural and molecular changes in human induced pluripotent stem cell-derived dopaminergic neurons. The study also found that this stimulation reversed cortisol-induced dendritic and cell-body shrinkage in an in-vitro model.

    Why the authors say this matters

    The authors conclude that these findings support low-frequency, low-intensity electrical stimulation as a neuromodulation approach targeting dopaminergic circuits in major depressive disorder and treatment-resistant depression. The study suggests this may be relevant because it produced effects similar to ketamine, a rapid-acting antidepressant.

    What the researchers tested

    The researchers exposed human iPSC-derived mesencephalic dopaminergic neurons to brief biphasic low-frequency, low-intensity electrical stimulation using a custom culture-compatible stimulator. They then measured structural plasticity three days later and used pharmacological blockers, quantitative PCR, and Western blot analyses to examine calcium influx, BDNF-TrkB-ERK-mTOR signaling, and dopamine D3 auto-receptor involvement. They also tested whether the stimulation could rescue cortisol-induced impairments in an in-vitro endocrine model of depression.

    What worked and what didn't

    A single 1-hour stimulation session at 4 mA increased maximal dendrite length, primary dendrite number, and soma area, with effects described as comparable to 1 μM ketamine. The stimulation rapidly increased ERK and p70-S6K phosphorylation, and blocking L-type voltage-gated calcium channels, TrkB, or mTOR prevented the structural remodeling. Dopamine D3 auto-receptor mRNA increased, and antagonizing this receptor attenuated the stimulation-induced plasticity; in cortisol-treated neurons, the stimulation fully reversed dendritic hypotrophy and soma shrinkage.

    What to keep in mind

    The study was done in human iPSC-derived neurons in vitro, so the findings are limited to this experimental model. The abstract does not describe clinical testing, long-term outcomes beyond the measured period, or additional limitations.

    • A single 1-hour low-frequency, low-intensity electrical stimulation session increased dendrite length, dendrite number, and soma area in human dopaminergic neurons.
    • The stimulation effects were described as comparable to 1 μM ketamine.
    • Blocking L-type voltage-gated calcium channels, TrkB, or mTOR prevented the structural changes.
    • Dopamine D3 auto-receptor antagonism reduced the stimulation-induced plasticity.
    • The stimulation reversed cortisol-induced dendritic hypotrophy and soma shrinkage in vitro.
  • NRTP improved real-time telemetry robustness for miniaturized implants

    NRTP improved real-time telemetry robustness for miniaturized implants

    What the study found

    The study found that the Neural Real-Time Telemetry Protocol (NRTP) provided more robust real-time telemetry for miniaturized neural implants than Bluetooth Low Energy (BLE), especially when signal conditions were poor. NRTP sustained zero data loss to a lower received signal strength than BLE and produced larger link-margin gains.

    Why the authors say this matters

    The authors conclude that NRTP could help make chronic, closed-loop studies with small-animal implants more practical. They also state that the link-margin gains may translate into better coverage, greater implant depth, or lower transmitter power for similar performance.

    What the researchers tested

    The researchers implemented NRTP on commercial 2.4 GHz hardware using static-length packets, immediate acknowledgments, bounded retransmissions, and a single RF channel. They compared NRTP with BLE using the same hardware, sweeping received signal strength and testing payload lengths, timing configurations, throughput, data loss, and current draw while evaluating retries, sample-level interleaving, and data overlapping alone and in combination.

    What worked and what didn't

    NRTP sustained zero data loss down to -75 dBm, while BLE performance degraded below -55 dBm because of throughput shortfalls under interference and deferred unlimited retries. Interleaving delayed score decline at lower signal strength by turning contiguous gaps into half-rate segments, and overlapping improved robustness but required twice the packet rate, which the authors say was too power-hungry for implant constraints. Across variants, NRTP gave higher scores and lower variability over a wider operating range than BLE, although BLE scored better at high signal strength because it used less current.

    What to keep in mind

    The abstract does not describe limitations beyond the tradeoff that overlapping was power-prohibitive for implant constraints. The reported link-margin and range values are stated for the tested setup and are presented as implications from the measured advantage, not as separate in vivo validation.

    • NRTP was designed for 2.4 GHz wireless telemetry from fully implanted, millimeter-scale neural devices.
    • The protocol used off-the-shelf hardware, not custom electronics or ASICs.
    • NRTP sustained zero data loss down to -75 dBm, while BLE degraded below -55 dBm.
    • Interleaving improved robustness by converting contiguous data gaps into half-rate segments.
    • Overlapping improved robustness but was too power-intensive for implant constraints.
    • The authors report link-margin gains of up to about 23 dB at first loss and about 11 dB at 0.5% loss.